Isolated adrenocorticotropin deficiency induced by pembrolizumab for hypopharyngeal cancer: A case report

Isolated adrenocorticotropin deficiency induced by pembrolizumab for hypopharyngeal cancer: A case report

Abstract We report a case of isolated adrenocorticotropin deficiency caused by pembrolizumab. This condition can be fatal, but its rarity causes under‐recognition. Oncologists should pay attention to adrenal insufficiency due to pembrolizumab.

Bibliographic Details
Main Authors: Koichiro Yamamoto, Kazuki Tokumasu, Kosuke Oka, Kou Hasegawa, Fumio Otsuka
Format: Article
Language:English
Published: Wiley 2021-06-01
Series:Clinical Case Reports
Subjects:
adrenal insufficiency
fever of unknown origin
hypophysitis
immune‐related adverse events
programmed cell death 1 protein inhibitor
Online Access:https://doi.org/10.1002/ccr3.4305

Internet

https://doi.org/10.1002/ccr3.4305

Similar Items